IO Biotech price target raised to $14 from $12 at H.C. Wainwright

finance.yahoo.com/news/io-biotech-price-target-raised-161116281.html

In This Article:
H.C. Wainwright raised the firm’s price target on IO Biotech (IOBT) to $14 from $12 and keeps a Buy rating on the shares following the Q1 report. The firm cites lower than expected operating expenses for the target increase. The analyst says IO’s Phase 3 advanced…

This story appeared on finance.yahoo.com, 2025-05-15 16:11:16.
The Entire Business World on a Single Page. Free to Use →